Investors / stance tracking

What Adam Parker is saying

Founder & CEO, Trivariate Research

4 dated public stances tracked since 2024-11-15, most recently 2025-08-01. Each line carries the date and the venue it came from; quotation marks mean verbatim. Methodology.

The stances below are c8alpha's editorial distillation of Adam Parker's public commentary — television, podcasts, and interviews — compiled by automated transcript analysis and dated to the episode they came from. They may lag the speaker's current view and may contain extraction errors. Text in quotation marks is verbatim from the episode; everything else is our paraphrase. Adam Parker is not affiliated with c8alpha and has not endorsed this page. Nothing here is investment advice.

Think we got something wrong? Report a misattribution — we correct it or take it down.

4
tracked stances
3
themes
0
side flips
2025-08-01
last heard

Raw direction-aware returns on public statements — long calls credited when the price rose, shorts when it fell, shorts capped at −100% — in a rising market this mostly measures who was long, not who has skill. Returns run from the stance date; calls are rarely closed publicly, so fixed 90-day / 180-day / 1-year horizons are used. A horizon shows only once it has fully matured, and only at 5+ scored stances.

Most-argued themes

ThemeStancesLeanMixLast
COST11 bearish2024-11-15
DEEP VALUE STOCKS (CHEAPEST DECILE)11 bearish2024-11-15
HIGH GROSS MARGIN EXPANSION STOCKS11 bullish2024-11-15

Tracked stances

bullish / bearish is a view they argued; owns / short is a position they said they hold.

2025-08-01 long MCK / long CAH / long COR basket The Compound · video
Drug distributors (MCK, CAH, COR) run at ~1% margins on enormous revenue bases; even modest AI-driven improvement to 1.5% margins produces ~50% earnings growth and multiple expansion analogous to Costco's re-rating
“I am recommending McKesson and Cardinal and Cencora — they're drug distributors”
90d +19.6% · 180d +25.4% · 1y +26.4%
Why Valuations Don't Matter | TCAF 202
2024-11-15 COST bearish The Compound · video
Stocks that breach 50x forward PE historically see multiple contraction 6-9 months later with only 24% sustaining the multiple two years out, making COST at 50x+ a poor new-money entry despite being a great business
“to walk in today and say for the first time ever, 'Geez, this Costco seems like a great investment today,' that seems like [bad]”
Buy the Election, Sell the Inauguration | TCAF 166
2024-11-15 DEEP VALUE STOCKS (CHEAPEST DECILE) bearish The Compound · video
The cheapest decile is cheap because the market is correctly pricing earnings impairment or obsolescence risk — the low multiple is a warning sign, not a contrarian opportunity, as downward revisions plus low multiples produce a double whammy
“The reason they're so cheap is the market's telling you something's wrong”
Buy the Election, Sell the Inauguration | TCAF 166
2024-11-15 HIGH GROSS MARGIN EXPANSION STOCKS bullish The Compound · video
Stocks outperforming by 20%+ are disproportionately those with the highest gross margin expansion, because rising gross margins signal pricing power, repeatable business models, and durable moats that make earnings more forecastable and defensible
“you don't want to short stocks where the gross margins are going up”
Buy the Election, Sell the Inauguration | TCAF 166

Idea Scout Weekly

Every Sunday: who said what across the tape we track — 845 voices, 2,419 episodes and articles — with side-flips and points of disagreement called out. Free. How we track it.

Free · double opt-in · unsubscribe in one click

Newest stances reach Brief subscribers first; these pages update on a one-week lag.